Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Hemato Oncology Testing Industry Research Report, Growth Trends and Competitive Analysis 2024-2030

Global Hemato Oncology Testing Industry Research Report, Growth Trends and Competitive Analysis 2024-2030

Industry: Medical Devices & Consumables

Published Date: 2024-04-17

Pages: 155 Pages

Report ld: 2704433

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Hemato Oncology Testing is a technology to predict the probability of disease by collecting genes (DNA) in human blood and analyzing and measuring the complete sequence of genes. Genetic testing can identify individuals' genes for disease, thereby preventing or treating tumours earlier.

Hematologic tumor detection is a technique to detect tumor genes on the basis of gene detection. Blood tumor detection services cover a wide range of solid tumors such as lung cancer, breast cancer, stomach cancer, esophageal cancer, colorectal cancer and liver cancer. Common tumors are detected. According to different tumor stages, blood tumor detection can be divided into four categories: tumor susceptibility gene screening, tumor early diagnosis, tumor individualized drug diagnosis, and tumor recovery monitoring. Tumor susceptibility gene screening can help people at high risk of genetic mutations to actively prevent tumors. Early diagnosis of cancer can help patients to find the disease as early as possible, thus greatly improving the survival rate of cancer patients. Individualized drug diagnosis for cancer patients to provide a more accurate cancer treatment program. Tumor recovery was monitored to assess the risk of recurrence.

In this paper, the current status and future development trend of hematoncology testing in China market are studied, focusing on the analysis of the companies that play an important role in the Chinese market, and focusing on the revenue, market share, market positioning, development plans, products and services of these companies in the Chinese market.

The global Hemato Oncology Testing market size was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. Fully considering the economic change by this health crisis, ctDNA Testing accounting for % of the Hemato Oncology Testing global market in 2023, is projected to value US$ million by 2030, growing at a revised % CAGR from 2024 to 2030. While Hospital segment is altered to an % CAGR throughout this forecast period.

In Chinese Market, Hemato Oncology Testing key players include Roche, Berry Genomics, Burning Rock Dx, BGI, Genetron, etc. Global top 5 manufacturers hold a share over 28%.

In terms of product, ctDNA Testing is the largest segment, with a share over 71%. And in terms of application, the largest application is Hospital, followed by Third Party Agency, Others.

The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Hemato Oncology Testing market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Hemato Oncology Testing market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Hemato Oncology Testing market. Readers of the report can become informed about current and future trends of the global Hemato Oncology Testing market and how they will impact market growth during the forecast period.

MARKET SEGMENTATION

By Company

Roche
Berry Genomics
Burning Rock Dx
BGI
Genetron
Haplox
Amoy Dx
Genosaber
YZY Biopharma
Wondfo

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

ctDNA Testing
CTC Testing
Other Testing

Segment by Application

Hospital
Third Party Agency
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.

Chapter 2: Revenue of Hemato Oncology Testing in global and regional level.

Chapter 3: Detailed analysis of Hemato Oncology Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: Asia Pacific by type, by application and by region, revenue for each segment.

Chapter 9: Latin America by type, by application and by country, revenue for each segment.

Chapter 10: Middle East and Africa, by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hemato Oncology Testing revenue, gross margin, and recent development, etc.

Chapter 12: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 13: Research Findings and Conclusion

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hemato Oncology Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 ctDNA Testing

1.2.3 CTC Testing

1.2.4 Other Testing

1.3 Market by Application

1.3.1 Global Hemato Oncology Testing Market Growth Rate by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Third Party Agency

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Market Perspective

2.1 Global Hemato Oncology Testing Market Size (2019-2030)

2.2 Hemato Oncology Testing Market Size across Key Geographies Worldwide: 2019 VS 2023 VS 2030

2.3 Global Hemato Oncology Testing Market Size by Region (2019-2024)

2.4 Global Hemato Oncology Testing Market Size Forecast by Region (2025-2030)

2.5 Global Top 10 Hemato Oncology Testing Countries Ranking by Market Size

3 Hemato Oncology Testing Competitive by Company

3.1 Global Hemato Oncology Testing Revenue by Players

3.1.1 Global Hemato Oncology Testing Revenue by Players (2019-2024)

3.1.2 Global Hemato Oncology Testing Market Share by Players (2019-2024)

3.2 Global Hemato Oncology Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Company Covered: Ranking by Hemato Oncology Testing Revenue

3.4 Global Hemato Oncology Testing Market Concentration Ratio

3.4.1 Global Hemato Oncology Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hemato Oncology Testing Revenue in 2023

3.5 Global Key Players of Hemato Oncology Testing Head office and Area Served

3.6 Global Key Players of Hemato Oncology Testing, Product and Application

3.7 Global Key Players of Hemato Oncology Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Global Hemato Oncology Testing Breakdown Data by Type

4.1 Global Hemato Oncology Testing Historic Revenue by Type (2019-2024)

4.2 Global Hemato Oncology Testing Forecasted Revenue by Type (2025-2030)

5 Global Hemato Oncology Testing Breakdown Data by Application

5.1 Global Hemato Oncology Testing Historic Market Size by Application (2019-2024)

5.2 Global Hemato Oncology Testing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Hemato Oncology Testing Revenue by Company (2022-2024)

6.2 North America Hemato Oncology Testing Revenue by Type (2019-2030)

6.3 North America Hemato Oncology Testing Revenue by Application (2019-2030)

6.4 North America Hemato Oncology Testing Revenue by Country (2019-2030)

6.4.1 United States

6.4.2 Canada

7 Europe

7.1 Europe Hemato Oncology Testing Revenue by Company (2022-2024)

7.2 Europe Hemato Oncology Testing Revenue by Type (2019-2030)

7.3 Europe Hemato Oncology Testing Revenue by Application (2019-2030)

7.4 Europe Hemato Oncology Testing Revenue by Country (2019-2030)

7.4.1 Germany

7.4.2 France

7.4.3 U.K.

7.4.4 Italy

7.4.5 Russia

8 Asia Pacific

8.1 Asia Pacific Hemato Oncology Testing Revenue by Company (2022-2024)

8.2 Asia Pacific Hemato Oncology Testing Revenue by Type (2019-2030)

8.3 Asia Pacific Hemato Oncology Testing Revenue by Application (2019-2030)

8.4 Asia Pacific Hemato Oncology Testing Revenue by Region (2019-2030)

8.4.1 China

8.4.2 Japan

8.4.3 South Korea

8.4.4 India

8.4.5 Australia

8.4.6 China Taiwan

8.4.7 Indonesia

8.4.8 Thailand

8.4.9 Malaysia

9 Latin America

9.1 Latin America Hemato Oncology Testing Revenue by Company (2022-2024)

9.2 Latin America Hemato Oncology Testing Revenue by Type (2019-2030)

9.3 Latin America Hemato Oncology Testing Revenue by Application (2019-2030)

9.4 Latin America Hemato Oncology Testing Revenue by Country (2019-2030)

9.4.1 Mexico

9.4.2 Brazil

9.4.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Hemato Oncology Testing Revenue by Company (2022-2024)

10.2 Middle East and Africa Hemato Oncology Testing Revenue by Type (2019-2030)

10.3 Middle East and Africa Hemato Oncology Testing Revenue by Application (2019-2030)

10.4 Middle East and Africa Hemato Oncology Testing Revenue by Country (2019-2030)

10.4.1 Turkey

10.4.2 Saudi Arabia

10.4.3 UAE

11 Company Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Hemato Oncology Testing Products and Services

11.1.4 Roche Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2019-2024)

11.1.5 Roche Hemato Oncology Testing SWOT Analysis

11.1.6 Roche Recent Development

11.2 Berry Genomics

11.2.1 Berry Genomics Company Details

11.2.2 Berry Genomics Business Overview

11.2.3 Berry Genomics Hemato Oncology Testing Products and Services

11.2.4 Berry Genomics Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2019-2024)

11.2.5 Berry Genomics Hemato Oncology Testing SWOT Analysis

11.2.6 Berry Genomics Recent Development

11.3 Burning Rock Dx

11.3.1 Burning Rock Dx Company Details

11.3.2 Burning Rock Dx Business Overview

11.3.3 Burning Rock Dx Hemato Oncology Testing Products and Services

11.3.4 Burning Rock Dx Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2019-2024)

11.3.5 Burning Rock Dx Hemato Oncology Testing SWOT Analysis

11.3.6 Burning Rock Dx Recent Development

11.4 BGI

11.4.1 BGI Company Details

11.4.2 BGI Business Overview

11.4.3 BGI Hemato Oncology Testing Products and Services

11.4.4 BGI Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2019-2024)

11.4.5 BGI Hemato Oncology Testing SWOT Analysis

11.4.6 BGI Recent Development

11.5 Genetron

11.5.1 Genetron Company Details

11.5.2 Genetron Business Overview

11.5.3 Genetron Hemato Oncology Testing Products and Services

11.5.4 Genetron Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2019-2024)

11.5.5 Genetron Hemato Oncology Testing SWOT Analysis

11.5.6 Genetron Recent Development

11.6 Haplox

11.6.1 Haplox Company Details

11.6.2 Haplox Business Overview

11.6.3 Haplox Hemato Oncology Testing Products and Services

11.6.4 Haplox Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2019-2024)

11.6.5 Haplox Hemato Oncology Testing SWOT Analysis

11.6.6 Haplox Recent Development

11.7 Amoy Dx

11.7.1 Amoy Dx Company Details

11.7.2 Amoy Dx Business Overview

11.7.3 Amoy Dx Hemato Oncology Testing Products and Services

11.7.4 Amoy Dx Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2019-2024)

11.7.5 Amoy Dx Hemato Oncology Testing SWOT Analysis

11.7.6 Amoy Dx Recent Development

11.8 Genosaber

11.8.1 Genosaber Company Details

11.8.2 Genosaber Business Overview

11.8.3 Genosaber Hemato Oncology Testing Products and Services

11.8.4 Genosaber Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2019-2024)

11.8.5 Genosaber Hemato Oncology Testing SWOT Analysis

11.8.6 Genosaber Recent Development

11.9 YZY Biopharma

11.9.1 YZY Biopharma Company Details

11.9.2 YZY Biopharma Business Overview

11.9.3 YZY Biopharma Hemato Oncology Testing Products and Services

11.9.4 YZY Biopharma Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2019-2024)

11.9.5 YZY Biopharma Hemato Oncology Testing SWOT Analysis

11.9.6 YZY Biopharma Recent Development

11.10 Wondfo

11.10.1 Wondfo Company Details

11.10.2 Wondfo Business Overview

11.10.3 Wondfo Hemato Oncology Testing Products and Services

11.10.4 Wondfo Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2019-2024)

11.10.5 Wondfo Hemato Oncology Testing SWOT Analysis

11.10.6 Wondfo Recent Development

12 Hemato Oncology Testing Market Dynamics

12.1 Hemato Oncology Testing Industry Trends

12.2 Hemato Oncology Testing Market Drivers

12.3 Hemato Oncology Testing Market Challenges

12.4 Hemato Oncology Testing Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Hemato Oncology Testing Market Size Growth Rate (CAGR) by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of ctDNA Testing

Table 3. Key Players of CTC Testing

Table 4. Key Players of Other Testing

Table 5. Global Hemato Oncology Testing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Hemato Oncology Testing Market Size (US$ Million) Growth Rate (CAGR) by Region: 2019 VS 2023 VS 2030

Table 7. Global Hemato Oncology Testing Revenue by Region (2019-2024) & (US$ Million)

Table 8. Global Hemato Oncology Testing Revenue Forecast by Region (2025-2030) & (US$ Million)

Table 9. Global Hemato Oncology Testing Market Size of Top 10 Countries, 2019 VS 2023 VS 2030, (US$ Million)

Table 10. Global Hemato Oncology Testing Revenue by Players (2019-2024) & (US$ Million)

Table 11. Global Hemato Oncology Testing Market Share by Players (2019-2024)

Table 12. Global Top Hemato Oncology Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemato Oncology Testing as of 2023)

Table 13. Ranking of Global Top Hemato Oncology Testing Companies by Revenue (US$ Million) in 2023

Table 14. Global 5 Largest Players Market Share by Hemato Oncology Testing Revenue (CR5 and HHI) & (2019-2024)

Table 15. Global Key Players of Hemato Oncology Testing, Headquarters and Area Served

Table 16. Global Key Players of Hemato Oncology Testing, Product and Application

Table 17. Global Key Players of Hemato Oncology Testing, Date of Enter into This Industry

Table 18. Mergers & Acquisitions, Expansion Plans

Table 19. Global Hemato Oncology Testing Market Size by Type (2019-2024) & (US$ Million)

Table 20. Global Hemato Oncology Testing Revenue Market Share by Type (2019-2024)

Table 21. Global Hemato Oncology Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 22. Global Hemato Oncology Testing Revenue Market Share by Type (2025-2030)

Table 23. Global Hemato Oncology Testing Market Size by Application (2019-2024) & (US$ Million)

Table 24. Global Hemato Oncology Testing Revenue Market Share by Application (2019-2024)

Table 25. Global Hemato Oncology Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 26. Global Hemato Oncology Testing Revenue Market Share by Application (2025-2030)

Table 27. North America Hemato Oncology Testing Revenue by Company (2022-2024) & (US$ Million)

Table 28. North America Hemato Oncology Testing Revenue by Type (2019-2024) & (US$ Million)

Table 29. North America Hemato Oncology Testing Revenue by Type (2025-2030) & (US$ Million)

Table 30. North America Hemato Oncology Testing Revenue by Application (2019-2024) & (US$ Million)

Table 31. North America Hemato Oncology Testing Revenue by Application (2025-2030) & (US$ Million)

Table 32. North America Hemato Oncology Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Hemato Oncology Testing Revenue by Country (2019-2024) & (US$ Million)

Table 34. North America Hemato Oncology Testing Revenue by Country (2025-2030) & (US$ Million)

Table 35. Europe Hemato Oncology Testing Revenue by Company (2022-2024) & (US$ Million)

Table 36. Europe Hemato Oncology Testing Revenue by Type (2019-2024) & (US$ Million)

Table 37. Europe Hemato Oncology Testing Revenue by Type (2025-2030) & (US$ Million)

Table 38. Europe Hemato Oncology Testing Revenue by Application (2019-2024) & (US$ Million)

Table 39. Europe Hemato Oncology Testing Revenue by Application (2025-2030) & (US$ Million)

Table 40. Europe Hemato Oncology Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Europe Hemato Oncology Testing Revenue by Country (2019-2024) & (US$ Million)

Table 42. Europe Hemato Oncology Testing Revenue by Country (2025-2030) & (US$ Million)

Table 43. Asia Pacific Hemato Oncology Testing Revenue by Company (2022-2024) & (US$ Million)

Table 44. Asia Pacific Hemato Oncology Testing Revenue by Type (2019-2024) & (US$ Million)

Table 45. Asia Pacific Hemato Oncology Testing Revenue by Type (2025-2030) & (US$ Million)

Table 46. Asia Pacific Hemato Oncology Testing Revenue by Application (2019-2024) & (US$ Million)

Table 47. Asia Pacific Hemato Oncology Testing Revenue by Application (2025-2030) & (US$ Million)

Table 48. Asia-Pacific Hemato Oncology Testing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 49. Asia Pacific Hemato Oncology Testing Revenue by Region (2019-2024) & (US$ Million)

Table 50. Asia Pacific Hemato Oncology Testing Revenue by Region (2025-2030) & (US$ Million)

Table 51. Latin America Hemato Oncology Testing Revenue by Company (2022-2024) & (US$ Million)

Table 52. Latin America Hemato Oncology Testing Revenue by Type (2019-2024) & (US$ Million)

Table 53. Latin America Hemato Oncology Testing Revenue by Type (2025-2030) & (US$ Million)

Table 54. Latin America Hemato Oncology Testing Revenue by Application (2019-2024) & (US$ Million)

Table 55. Latin America Hemato Oncology Testing Revenue by Application (2025-2030) & (US$ Million)

Table 56. Latin America Hemato Oncology Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 57. Latin America Hemato Oncology Testing Revenue by Country (2019-2024) & (US$ Million)

Table 58. Latin America Hemato Oncology Testing Revenue by Country (2025-2030) & (US$ Million)

Table 59. Middle East and Africa Hemato Oncology Testing Revenue by Company (2022-2024) & (US$ Million)

Table 60. Middle East and Africa Hemato Oncology Testing Revenue by Type (2019-2024) & (US$ Million)

Table 61. Middle East and Africa Hemato Oncology Testing Revenue by Type (2025-2030) & (US$ Million)

Table 62. Middle East and Africa Hemato Oncology Testing Revenue by Application (2019-2024) & (US$ Million)

Table 63. Middle East and Africa Hemato Oncology Testing Revenue by Application (2025-2030) & (US$ Million)

Table 64. Middle East and Africa Hemato Oncology Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 65. Middle East and Africa Hemato Oncology Testing Revenue by Country (2019-2024) & (US$ Million)

Table 66. Middle East and Africa Hemato Oncology Testing Revenue by Country (2025-2030) & (US$ Million)

Table 67. Roche Company Details

Table 68. Roche Business Overview

Table 69. Roche Hemato Oncology Testing Product and Services

Table 70. Roche Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2019-2024) & (US$ Million)

Table 71. Roche Hemato Oncology Testing SWOT Analysis

Table 72. Roche Recent Development

Table 73. Berry Genomics Company Details

Table 74. Berry Genomics Business Overview

Table 75. Berry Genomics Hemato Oncology Testing Product and Services

Table 76. Berry Genomics Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2019-2024) & (US$ Million)

Table 77. Berry Genomics Hemato Oncology Testing SWOT Analysis

Table 78. Berry Genomics Recent Development

Table 79. Burning Rock Dx Company Details

Table 80. Burning Rock Dx Business Overview

Table 81. Burning Rock Dx Hemato Oncology Testing Product and Services

Table 82. Burning Rock Dx Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2019-2024) & (US$ Million)

Table 83. Burning Rock Dx Hemato Oncology Testing SWOT Analysis

Table 84. Burning Rock Dx Recent Development

Table 85. BGI Company Details

Table 86. BGI Business Overview

Table 87. BGI Hemato Oncology Testing Product and Services

Table 88. BGI Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2019-2024) & (US$ Million)

Table 89. BGI Hemato Oncology Testing SWOT Analysis

Table 90. BGI Recent Development

Table 91. Genetron Company Details

Table 92. Genetron Business Overview

Table 93. Genetron Hemato Oncology Testing Product and Services

Table 94. Genetron Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2019-2024) & (US$ Million)

Table 95. Genetron Hemato Oncology Testing SWOT Analysis

Table 96. Genetron Recent Development

Table 97. Haplox Company Details

Table 98. Haplox Business Overview

Table 99. Haplox Hemato Oncology Testing Product and Services

Table 100. Haplox Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2019-2024) & (US$ Million)

Table 101. Haplox Hemato Oncology Testing SWOT Analysis

Table 102. Haplox Recent Development

Table 103. Amoy Dx Company Details

Table 104. Amoy Dx Business Overview

Table 105. Amoy Dx Hemato Oncology Testing Product and Services

Table 106. Amoy Dx Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2019-2024) & (US$ Million)

Table 107. Amoy Dx Hemato Oncology Testing SWOT Analysis

Table 108. Amoy Dx Recent Development

Table 109. Genosaber Company Details

Table 110. Genosaber Business Overview

Table 111. Genosaber Hemato Oncology Testing Product and Services

Table 112. Genosaber Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2019-2024) & (US$ Million)

Table 113. Genosaber Hemato Oncology Testing SWOT Analysis

Table 114. Genosaber Recent Development

Table 115. YZY Biopharma Company Details

Table 116. YZY Biopharma Business Overview

Table 117. YZY Biopharma Hemato Oncology Testing Product and Services

Table 118. YZY Biopharma Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2019-2024) & (US$ Million)

Table 119. YZY Biopharma Hemato Oncology Testing SWOT Analysis

Table 120. YZY Biopharma Recent Development

Table 121. Wondfo Company Details

Table 122. Wondfo Business Overview

Table 123. Wondfo Hemato Oncology Testing Product and Services

Table 124. Wondfo Hemato Oncology Testing Revenue in Hemato Oncology Testing Business (2019-2024) & (US$ Million)

Table 125. Wondfo Hemato Oncology Testing SWOT Analysis

Table 126. Wondfo Recent Development

Table 127. Hemato Oncology Testing Market Trends

Table 128. Hemato Oncology Testing Market Drivers

Table 129. Hemato Oncology Testing Market Challenges

Table 130. Hemato Oncology Testing Market Restraints

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

List of Figures

Figure 1. Hemato Oncology Testing Product Picture

Figure 2. Global Hemato Oncology Testing Market Size by Type (US$ Million): 2019 VS 2023 VS 2030

Figure 3. Global Hemato Oncology Testing Market Share by Type: 2023 VS 2030

Figure 4. ctDNA Testing Features

Figure 5. CTC Testing Features

Figure 6. Other Testing Features

Figure 7. Global Hemato Oncology Testing Market Size by Application (US$ Million): 2019 VS 2023 VS 2030

Figure 8. Global Hemato Oncology Testing Market Share by Application: 2023 VS 2030

Figure 9. Hospital

Figure 10. Third Party Agency

Figure 11. Others

Figure 12. Hemato Oncology Testing Report Years Considered

Figure 13. Global Hemato Oncology Testing Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Hemato Oncology Testing Market Size 2019-2030 (US$ Million)

Figure 15. Global Hemato Oncology Testing Market Size Market Share by Region: 2023 VS 2030

Figure 16. Global Hemato Oncology Testing Revenue Market Share by Region in 2019 VS 2023

Figure 17. Global Hemato Oncology Testing Revenue Market Share Forecast by Region (2025-2030)

Figure 18. Global Top 10 Hemato Oncology Testing Countries Ranking by Market Size (US$ Million) in 2023

Figure 19. Global Hemato Oncology Testing Market Size of Top 10 Countries, 2019 VS 2023 VS 2030, (US$ Million)

Figure 20. Global Hemato Oncology Testing Market Share by Players in 2023

Figure 21. Global Top Hemato Oncology Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemato Oncology Testing as of 2023)

Figure 22. The Top 10 and 5 Players Market Share by Hemato Oncology Testing Revenue in 2023

Figure 23. North America Hemato Oncology Testing Revenue Market Share by Company in 2023

Figure 24. North America Hemato Oncology Testing Revenue Market Share by Type (2019-2030)

Figure 25. North America Hemato Oncology Testing Revenue Market Share by Application (2019-2030)

Figure 26. North America Hemato Oncology Testing Revenue Share by Country (2019-2030)

Figure 27. United States Hemato Oncology Testing Revenue (2019-2030) & (US$ Million)

Figure 28. Canada Hemato Oncology Testing Revenue (2019-2030) & (US$ Million)

Figure 29. Europe Hemato Oncology Testing Revenue Market Share by Company in 2023

Figure 30. Europe Hemato Oncology Testing Revenue Market Share by Type (2019-2030)

Figure 31. Europe Hemato Oncology Testing Revenue Market Share by Application (2019-2030)

Figure 32. Europe Hemato Oncology Testing Revenue Share by Country (2019-2030)

Figure 33. Germany Hemato Oncology Testing Revenue (2019-2030) & (US$ Million)

Figure 34. France Hemato Oncology Testing Revenue (2019-2030) & (US$ Million)

Figure 35. U.K. Hemato Oncology Testing Revenue (2019-2030) & (US$ Million)

Figure 36. Italy Hemato Oncology Testing Revenue (2019-2030) & (US$ Million)

Figure 37. Russia Hemato Oncology Testing Revenue (2019-2030) & (US$ Million)

Figure 38. Asia Pacific Hemato Oncology Testing Revenue Market Share by Company in 2023

Figure 39. Asia Pacific Hemato Oncology Testing Revenue Market Share by Type (2019-2030)

Figure 40. Asia Pacific Hemato Oncology Testing Revenue Market Share by Application (2019-2030)

Figure 41. Asia Pacific Hemato Oncology Testing Revenue Share by Region (2019-2030)

Figure 42. China Hemato Oncology Testing Revenue (2019-2030) & (US$ Million)

Figure 43. Japan Hemato Oncology Testing Revenue (2019-2030) & (US$ Million)

Figure 44. South Korea Hemato Oncology Testing Revenue (2019-2030) & (US$ Million)

Figure 45. India Hemato Oncology Testing Revenue (2019-2030) & (US$ Million)

Figure 46. Australia Hemato Oncology Testing Revenue (2019-2030) & (US$ Million)

Figure 47. China Taiwan Hemato Oncology Testing Revenue (2019-2030) & (US$ Million)

Figure 48. Indonesia Hemato Oncology Testing Revenue (2019-2030) & (US$ Million)

Figure 49. Thailand Hemato Oncology Testing Revenue (2019-2030) & (US$ Million)

Figure 50. Malaysia Hemato Oncology Testing Revenue (2019-2030) & (US$ Million)

Figure 51. Latin America Hemato Oncology Testing Revenue Market Share by Company in 2023

Figure 52. Latin America Hemato Oncology Testing Revenue Market Share by Type (2019-2030)

Figure 53. Latin America Hemato Oncology Testing Revenue Market Share by Application (2019-2030)

Figure 54. Latin America Hemato Oncology Testing Revenue Share by Country (2019-2030)

Figure 55. Mexico Hemato Oncology Testing Revenue (2019-2030) & (US$ Million)

Figure 56. Brazil Hemato Oncology Testing Revenue (2019-2030) & (US$ Million)

Figure 57. Argentina Hemato Oncology Testing Revenue (2019-2030) & (US$ Million)

Figure 58. Middle East and Africa Hemato Oncology Testing Revenue Market Share by Company in 2023

Figure 59. Middle East and Africa Hemato Oncology Testing Revenue Market Share by Type (2019-2030)

Figure 60. Middle East and Africa Hemato Oncology Testing Revenue Market Share by Application (2019-2030)

Figure 61. Middle East and Africa Hemato Oncology Testing Revenue Share by Country (2019-2030)

Figure 62. Turkey Hemato Oncology Testing Revenue (2019-2030) & (US$ Million)

Figure 63. Saudi Arabia Hemato Oncology Testing Revenue (2019-2030) & (US$ Million)

Figure 64. UAE Hemato Oncology Testing Revenue (2019-2030) & (US$ Million)

Figure 65. Roche Revenue Growth Rate in Hemato Oncology Testing Business (2019-2024)

Figure 66. Berry Genomics Revenue Growth Rate in Hemato Oncology Testing Business (2019-2024)

Figure 67. Burning Rock Dx Revenue Growth Rate in Hemato Oncology Testing Business (2019-2024)

Figure 68. BGI Revenue Growth Rate in Hemato Oncology Testing Business (2019-2024)

Figure 69. Genetron Revenue Growth Rate in Hemato Oncology Testing Business (2019-2024)

Figure 70. Haplox Revenue Growth Rate in Hemato Oncology Testing Business (2019-2024)

Figure 71. Amoy Dx Revenue Growth Rate in Hemato Oncology Testing Business (2019-2024)

Figure 72. Genosaber Revenue Growth Rate in Hemato Oncology Testing Business (2019-2024)

Figure 73. YZY Biopharma Revenue Growth Rate in Hemato Oncology Testing Business (2019-2024)

Figure 74. Wondfo Revenue Growth Rate in Hemato Oncology Testing Business (2019-2024)

Figure 75. Bottom-up and Top-down Approaches for This Report

Figure 76. Data Triangulation

Figure 77. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Hemato Oncology Testing market? zhanKai

The top companies in the global Hemato Oncology Testing market are Roche、Berry Genomics、Burning Rock Dx.

Related Reports

Global Hemato Oncology Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemato Oncology Testing market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 79
USD 4250.00
(Single User License)
Global Hemato Oncology Testing Market Research Report 2026
The global Hemato Oncology Testing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-05
Pages: 102
USD 2900.00
(Single User License)
Hemato Oncology Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemato Oncology Testing was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-05
Pages: 86
USD 3950.00
(Single User License)
Global Hemato Oncology Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemato Oncology Testing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 78
USD 4250.00
(Single User License)
Global Hemato Oncology Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemato Oncology Testing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-08
Pages: 126
USD 4900.00
(Single User License)
Hemato Oncology Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemato Oncology Testing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 94
USD 3950.00
(Single User License)
Global Hemato Oncology Testing Market Research Report 2025
The global market for Hemato Oncology Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-19
Pages: 73
USD 2900.00
(Single User License)
Global Hemato Oncology Testing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemato Oncology Testing is a technology to predict the probability of disease by collecting genes (DNA) in human blood and analyzing and measuring the complete sequence of genes. Genetic testing can identify individuals' genes for disease, thereby preventing or treating tumours earlier.
Published Date: 2024-04-16
Pages: 151
USD 5900.00
(Single User License)
Global Hemato Oncology Testing Market Insights, Forecast to 2030
Hemato Oncology Testing is a technology to predict the probability of disease by collecting genes (DNA) in human blood and analyzing and measuring the complete sequence of genes. Genetic testing can identify individuals' genes for disease, thereby preventing or treating tumours earlier.
Published Date: 2024-04-07
Pages: 114
USD 4900.00
(Single User License)
Hemato Oncology Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Hemato Oncology Testing is a technology to predict the probability of disease by collecting genes (DNA) in human blood and analyzing and measuring the complete sequence of genes. Genetic testing can identify individuals' genes for disease, thereby preventing or treating tumours earlier.
Published Date: 2024-01-18
Pages: 103
USD 3950.00
(Single User License)

Global Hemato Oncology Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemato Oncology Testing market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 79
USD 4250.00 (Single User License)
Global Hemato Oncology Testing Market Research Report 2026
The global Hemato Oncology Testing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-05
Pages: 102
USD 2900.00 (Single User License)
Hemato Oncology Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemato Oncology Testing was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-05
Pages: 86
USD 3950.00 (Single User License)
Global Hemato Oncology Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemato Oncology Testing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 78
USD 4250.00 (Single User License)
Global Hemato Oncology Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemato Oncology Testing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-08
Pages: 126
USD 4900.00 (Single User License)
Hemato Oncology Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemato Oncology Testing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 94
USD 3950.00 (Single User License)
Global Hemato Oncology Testing Market Research Report 2025
The global market for Hemato Oncology Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-19
Pages: 73
USD 2900.00 (Single User License)
Global Hemato Oncology Testing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemato Oncology Testing is a technology to predict the probability of disease by collecting genes (DNA) in human blood and analyzing and measuring the complete sequence of genes. Genetic testing can identify individuals' genes for disease, thereby preventing or treating tumours earlier.
Published: 2024-04-16
Pages: 151
USD 5900.00 (Single User License)
Global Hemato Oncology Testing Market Insights, Forecast to 2030
Hemato Oncology Testing is a technology to predict the probability of disease by collecting genes (DNA) in human blood and analyzing and measuring the complete sequence of genes. Genetic testing can identify individuals' genes for disease, thereby preventing or treating tumours earlier.
Published: 2024-04-07
Pages: 114
USD 4900.00 (Single User License)
Hemato Oncology Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Hemato Oncology Testing is a technology to predict the probability of disease by collecting genes (DNA) in human blood and analyzing and measuring the complete sequence of genes. Genetic testing can identify individuals' genes for disease, thereby preventing or treating tumours earlier.
Published: 2024-01-18
Pages: 103
USD 3950.00 (Single User License)